Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure.
Of 137 patients (mean age 63 years) who underwent hemodialysis for chronic renal failure, 65 (47%) had mitral valve calcium, mitral annular calcium, or aortic valve calcium. Thirty-eight of 65 patients (59%) who had valve calcium died at 3.5-year follow-up versus 21 of 72 patients (29%) who did not have valve calcium and who died at 4.3-year follow-up (p = 0.0005).
Varma
Raja
R
Department of Medicine, Cardiology and Renal Divisions, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA.
Aronow
Wilbert S
WS
McClung
John A
JA
Garrick
Renee
R
Vistainer
Paul F
PF
Weiss
Melvin B
MB
Belkin
Robert N
RN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve; D001161:Arteriosclerosis / Q000401:mortality*; D002114:Calcinosis / Q000175:diagnosis / Q000401:mortality*; D002423:Cause of Death; D003327:Coronary Disease / Q000175:diagnosis / Q000401:mortality*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000401:mortality*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D009203:Myocardial Infarction / Q000401:mortality; D006435:Renal Dialysis; D018570:Risk Assessment